Related Experiment Videos
IGF1 receptor expression protects against microenvironmental stress found in the solid tumor
Shani Peretz1, Charlotte Kim, Sara Rockwell
1Departments of Therapeutic Radiology, Yale University School of Medicine, P.O. Box 208040, New Haven, Connecticut 06520-8040, USA.
Radiation Research
|July 11, 2002
Summary
The insulin-like growth factor 1 receptor (IGF1R) helps cancer cells survive harsh tumor conditions like low oxygen and nutrients. Upregulating IGF1R promotes cancer cell adaptation and survival in the tumor microenvironment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The insulin-like growth factor 1 receptor (IGF1R) is a tyrosine kinase transmembrane receptor crucial for normal cell growth.
- IGF1R overexpression in cell culture promotes cell transformation and survival against cytotoxic agents.
- Tumor microenvironments are characterized by heterogeneity, including hypoxia, low pH, and low glucose.
Purpose of the Study:
- To investigate the role of IGF1R in cancer cell survival under conditions mimicking the tumor microenvironment (hypoxia, low pH, low glucose).
- To determine if cancer cells can adapt to these stressful conditions by altering IGF1R expression.
Main Methods:
- Overexpression of IGF1R in cell culture.
- Targeted gene disruption to create IGF1R-deficient cells.
- Exposure of cells to hypoxia, low pH, and low glucose.
- Analysis of cell survival rates.
- Activation of the IGF1R gene promoter analysis.
- Immunoblot analysis to detect IGF1R protein levels.
Main Results:
- Overexpression of IGF1R enhanced cancer cell survival under hypoxia, low pH, and low glucose conditions.
- IGF1R-deficient cells exhibited reduced survival in these stressful conditions compared to normal cells.
- Cancer cells activated the IGF1R gene promoter in response to hypoxia.
- Hypoxia exposure led to increased IGF1R protein levels.
Conclusions:
- The tumor microenvironment, particularly hypoxia, can induce IGF1R expression in cancer cells.
- Increased IGF1R expression enhances cancer cell survival and adaptation to the challenging tumor microenvironment.
- IGF1R represents a potential therapeutic target for overcoming cancer cell resistance in hypoxic tumors.